Over 2,100 attendees and more than 220 exhibitors gathered over the course of the three-day congress.
The International Biotechnology Meeting, BIOSPAIN 2023, held from September 26 to 28 at Fira de Barcelona – Montjuïc, organized by the Spanish Association of Biotech Companies (AseBio) in collaboration with Biocat, the Barcelona City Council, and the Government of Catalonia, has concluded its eleventh edition with record-breaking participation figures.
Participation of CEBR
In the framework of the event, CEBR organised the final event of Safe-n-MedTech, a 4-year project that has built an innovative open access platform to offer companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices.
The event was split in 2 sessions:
Session 1: “Open Innovation for Nanotech in Life Sciences”
An interesting panel moderated by Anaïs Le Corvec, Managing Director at Council of European BioRegions – CEBR that gathered experts and leaders from diverse backgrounds.
We could explore the concept of OITB – Open Innovation Test Beds and discuss about the challenges, complexities and opportunities that OITBs have, highlighting the importance of keeping the ecosystem in Europe and the need to standardise the quality of the work and outputs.
Session 2: “NanoCocktail: meet the Nano and MedTech community!”
A networking session to meet and exchange with the Nano ecosystem and where we could offer an overview of the project and its future sustainability.
Besides this, CEBR participated in the “Biomanufacturing is the Future of Europe” panel, coordinated by Biocat and focused on the transformative role biomanufacturing is playing in the future of Europe and ensuring the sustainability of the bioproduction industry. Anaïs Le Corvec moderated the panel discussion, which featured Nerea Garcia, plant director at Reig Jofré; Hilary Stiss, senior manager for International Affairs at the Biotechnology Innovation Organization; Sara Secall, parter at Inveready; Claire Skentelbery, director general at EuropaBio; and Damaso Molero, CEO of 3P Biopharmaceuticals.
A panel focused on the transformative role of biomanufacturing in shaping the future of Europe to ensure the sustainability of the bioproduction industry, which are some of the main goals of our BioMan4R2 project, in which CEBR is a partner.
Finally, a panel organised by the EU funded EDAH project -in which CEBR is also a partner- took place. During this session “Health data for innovative medicine and the health of the future, EDAH project” the panelists analyzed the barriers and drivers for making the most of the potential for secondary use of health data and preparing the industry to participate and contribute to this transformation.
The session was moderated by Montserrat Daban, Biocat director of Science Policy and Internationalization and president of the Council of European BioRegions (CEBR), and featured Antonio Alcolea, deputy director general of Data Economy and Digitalization (Secretary of State for Digitalization and Artificial Intelligence) in the Ministry of Economy and Digital Transformation; Cristina Nadal, Executive Policy director at MSD; Sergio Muñoz, Chief Innovation Officer and Digital Health and Emerging Technologies director at FENIN; Petri Lehto, senior advisor in the Health Data 2030 project at SITRA; and Iza Alfany, managing director at EIT Health.
A great event were we could meet and socialise with some of the CEBR members!
